Interpace Biosciences Inc (IDXG)
3.09
-0.19
(-5.79%)
USD |
OTCM |
Nov 14, 15:46
Interpace Biosciences Total Assets (Quarterly): 12.97M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 12.97M |
March 31, 2024 | 12.14M |
December 31, 2023 | 13.02M |
September 30, 2023 | 14.25M |
June 30, 2023 | 15.94M |
March 31, 2023 | 15.88M |
December 31, 2022 | 15.98M |
September 30, 2022 | 15.29M |
June 30, 2022 | 35.49M |
March 31, 2022 | 38.36M |
December 31, 2021 | 38.43M |
September 30, 2021 | 40.31M |
June 30, 2021 | 43.18M |
March 31, 2021 | 43.86M |
December 31, 2020 | 45.68M |
September 30, 2020 | 50.70M |
June 30, 2020 | 78.43M |
March 31, 2020 | 78.51M |
December 31, 2019 | 51.54M |
September 30, 2019 | 74.67M |
June 30, 2019 | 50.33M |
March 31, 2019 | 54.38M |
December 31, 2018 | 31.13M |
September 30, 2018 | 49.80M |
June 30, 2018 | 51.36M |
Date | Value |
---|---|
March 31, 2018 | 53.10M |
December 31, 2017 | 53.60M |
September 30, 2017 | 50.39M |
June 30, 2017 | 53.74M |
March 31, 2017 | 46.98M |
December 31, 2016 | 41.78M |
September 30, 2016 | 45.96M |
June 30, 2016 | 53.51M |
March 31, 2016 | 56.78M |
December 31, 2015 | 67.71M |
September 30, 2015 | 99.29M |
June 30, 2015 | 107.57M |
March 31, 2015 | 112.61M |
December 31, 2014 | 115.91M |
September 30, 2014 | 62.23M |
June 30, 2014 | 59.46M |
March 31, 2014 | 65.38M |
December 31, 2013 | 69.06M |
September 30, 2013 | 73.21M |
June 30, 2013 | 77.28M |
March 31, 2013 | 82.80M |
December 31, 2012 | 78.45M |
September 30, 2012 | 106.08M |
June 30, 2012 | 104.82M |
March 31, 2012 | 108.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
12.14M
Minimum
Mar 2024
78.51M
Maximum
Mar 2020
34.73M
Average
38.36M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
Fonar Corp | 214.25M |
XWELL Inc | 36.29M |
ProPhase Labs Inc | 93.68M |
Applied DNA Sciences Inc | 16.69M |
Veracyte Inc | 1.275B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 72.00M |
Shareholders Equity (Quarterly) | -59.03M |
Debt to Equity Ratio | -0.1149 |
Current Ratio | 0.5342 |
Net Debt Paydown Yield | 26.02% |